Mednet Logo
HomePrimary CareQuestion

When and how should we be stopping GLP-1 Receptor Agonist/Dual Agonist therapy?

1
1 Answers
Mednet Member
Mednet Member
Endocrinology · City of Hope Comprehensive Cancer Center

I usually continue for 3-4 years, the tapering down slowly over 1 year period, buy then the set point for energy expenditure and appetite likely is changed.

Register or Sign In to see full answer